ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
6,081.32
-0.08%
Dow Jones
44,234.63
0.18%
US Dollar vs MXN
20.4532
-0.24%
Brent Oil
78.815
0.61%
Bitcoin
104,568.06
0.92%
Pepperstone
Advertisement
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Europa
  5. EU

  6. Celyad Oncology SA (CYAD) Cotización

Celyad Oncology SA

Celyad Oncology SA (CYAD)

EU
0.495
0.0085
( 1.75% )
Actualizado: 05:04:02
Delayed by 15 minutes

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Premium

Estadísticas y detalles clave

Último Precio
0.495
Postura de Compra
0.482
Postura de Venta
0.4965
Volume Operado de la Acción
4,048
0.482 Rango del Día 0.498
0.212 Rango de 52 semanas 1.22
Capitalización de Mercado [m]
20.507M
Precio Anterior
0.4865
Precio de Apertura
0.498
Hora
50
@
0.495
Última hora de negociación
05:04:02
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
104,771
Acciones en circulación
41,429,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-2.40
Beneficio por acción (BPA)
-0.2
turnover
102k
Beneficio neto
-8.45M

Acerca de Celyad Oncology SA

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
www.celyad.com
Sede
Mont-saint-guibert, Walloon Brabant, Bel
Fundado
-
Celyad Oncology SA is listed in the Pharmaceutical Preparations sector of the Euronext with ticker CYAD. The last closing price for Celyad Oncology was 0.49 €. Over the last year, Celyad Oncology shares have traded in a share price range of 0.212 € to 1.22 €.

Celyad Oncology currently has 41,429,000 shares in issue. The market capitalisation of Celyad Oncology is 20.16 € million. Celyad Oncology has a price to earnings ratio (PE ratio) of -2.40.

CYAD Últimas noticias

Más noticias

Celyad Oncology Présentera au Congrès Annuel SITC 2024

Regulatory News: Celyad Oncology (Euronext: CYAD) (la “Société”), annonce aujourd'hui la présentation de deux posters lors de la 39e réunion annuelle de la Society for Immunotherapy of Cancer...

07 Octubre 2024
Business Wire

Celyad Oncology announces intention to terminate SEC reporting obligations

MONT-SAINT-GUIBERT, Belgium, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext: CYAD) (“Celyad Oncology” or the “Company”) announces that it will voluntarily file a Form 15F with...

08 Febrero 2024
GlobeNewswire Inc.

Celyad Oncology provides fourth quarter 2023 business update and 2024 outlook

Three main pillars to unlock the potential of proprietary technology platforms and intellectual property: A proprietary non-gene editing technology platform based on multiplexing of short hairpin...

16 Enero 2024
GlobeNewswire Inc.

Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)

MONT-SAINT-GUIBERT, Belgium, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext: CYAD) (“Celyad Oncology” or the “Company”) today announces, in accordance with Article 14 of the...

20 Diciembre 2023
GlobeNewswire Inc.

Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)

MONT-SAINT-GUIBERT, Belgium, Dec. 15, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology (Euronext: CYAD) (the “Company” or “Celyad Oncology”), today announces that 6,500,000 shares of CFIP CLYD (UK...

15 Diciembre 2023
GlobeNewswire Inc.

Celyad announces management change

MONT-SAINT-GUIBERT, Belgium, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology (Euronext: CYAD), a cutting-edge biotechnology company dedicated to pioneering the discovery and advancement of...

04 Diciembre 2023
GlobeNewswire Inc.

Publication of a transparency notification received from Tolefi SA (Article 14 §1 of the Law of 2 May 2007)

MONT-SAINT-GUIBERT, Belgium, Dec. 01, 2023 (GLOBE NEWSWIRE) -- regulated information – Celyad Oncology SA (Euronext: CYAD) (“Celyad Oncology” or the “Company”) today announced, in accordance...

01 Diciembre 2023
GlobeNewswire Inc.

Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)

MONT-SAINT-GUIBERT, Belgium, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext: CYAD) (“Celyad Oncology” or the “Company”) today announced, in accordance with Article 14 of the...

21 Noviembre 2023
GlobeNewswire Inc.

Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)

MONT-SAINT-GUIBERT, Belgium, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology (Euronext: CYAD) (the “Company” or “Celyad Oncology”), today announces the below information following the...

14 Noviembre 2023
GlobeNewswire Inc.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.052-9.506398537480.5470.5470.482113030.51851066DE
4-0.212-29.98585572840.7070.7340.482332930.60316962DE
120.22800.2751.220.26151047710.73329254DE
260.23388.93129770990.2621.220.212556230.65047585DE
520.13537.50.361.220.212376550.57092586DE
156-2.905-85.44117647063.43.40.212391931.07587205DE
260-10.425-95.46703296710.9212.080.212412633.27375779DE

CYAD - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Celyad Oncology?
El precio actual de las acciones de Celyad Oncology es 0.495 €
¿Cuántas acciones de Celyad Oncology están en circulación?
Celyad Oncology tiene 41,429,000 acciones en circulación
¿Cuál es la capitalización de mercado de Celyad Oncology?
La capitalización de mercado de Celyad Oncology es EUR 20.16M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Celyad Oncology?
Celyad Oncology ha negociado en un rango de 0.212 € a 1.22 € durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Celyad Oncology?
El ratio precio/beneficio de Celyad Oncology es -2.4
¿Cuál es el ratio de efectivo a ventas de Celyad Oncology?
El ratio de efectivo a ventas de Celyad Oncology es 196
¿Cuál es la moneda de reporte de Celyad Oncology?
Celyad Oncology presenta sus resultados financieros en EUR
¿Cuál es el último ingresos anual de Celyad Oncology?
El último ingresos anual de Celyad Oncology es EUR 102k
¿Cuál es el último beneficio anual de Celyad Oncology?
El último beneficio anual de Celyad Oncology es EUR -8.45M
¿Cuál es la dirección registrada de Celyad Oncology?
La dirección registrada de Celyad Oncology es AXIS BUSINESS PARK, RUE ANDRE DUMONT 9, MONT-SAINT-GUIBERT, WALLOON BRABANT, 1435
¿Cuál es la dirección del sitio web de Celyad Oncology?
La dirección del sitio web de Celyad Oncology es www.celyad.com
¿En qué sector industrial opera Celyad Oncology?
Celyad Oncology opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
ALNMRNamR SA
0.48 €
(118.18%)
172.3k
MLGEQGentlemen S Equity SA
0.0295 €
(34.09%)
9.18k
GNROGeNeuro SA
0.181 €
(27.46%)
1.11M
ALTAILighton
19.59 €
(17.66%)
49.55k
VACBSPierre & Vacances
0.06 €
(16.73%)
72.41k
MLERHElix Rental Housing Socimi ii SA
2.00 €
(-90.00%)
1
MLAAHAmatheon Agri Holding NV
0.0195 €
(-32.76%)
1
ALSPWSpineway
0.1075 €
(-18.56%)
2.23M
ALSAFSAFE
0.022 €
(-16.98%)
491.9k
ALALOAcheterLouerFR
0.0582 €
(-16.86%)
84.42k
ATOAtos SE
0.0022 €
(4.76%)
286.61M
BCPBanco Comercial Portugues SA
0.5122 €
(0.59%)
46.39M
ALVERVergnet
0.0016 €
(0.00%)
26.5M
ALMASMastrad
0.0226 €
(7.62%)
18.21M
ALCYBCybergun
0.0002 €
(0.00%)
10.01M

Discusión

Ver feed completo
georgie18 georgie18 2 minutos hace
SGLY...Added the $3.05 Dip...🥳

georgie18

Member Level
Re: georgie18 post# 135

Thursday, January 23, 2025 7:48:02 AM

Post#
136
of 136
SGLY...$3.71...🥳

georgie18

Mem
SGLY
stocktowatch stocktowatch 2 minutos hace
$CSDX Company Update :
Our newest product is not just another solution; it’s a response to a growing $30B+ global market need. Engineered to provide unrivaled protection, while reducing operational costs, this innovation will entirely redefine hygiene standards.

With a multi-c
CSDX
HD2001 HD2001 2 minutos hace
Axim low float and on the move from .0019
AXIM
Gizzer211 Gizzer211 2 minutos hace
I think UMAV got a little ahead of itself
UMAV
peanutz peanutz 2 minutos hace
Going to bounce hard !
UMAV
georgie18 georgie18 2 minutos hace
SGLY...Added the $3.05 Dip...🥳

georgie18

Member Level
Re: georgie18 post# 135

Thursday, January 23, 2025 7:48:02 AM

Post#
136
of 136
SGLY...$3.71...🥳

georgie18

Mem
SGLY
georgie18 georgie18 2 minutos hace
SGLY...Added the $3.05 Dip...🥳

georgie18

Member Level
Re: georgie18 post# 135

Thursday, January 23, 2025 7:48:02 AM

Post#
136
of 136
SGLY...$3.71...🥳

georgie18

Mem
SGLY
ProfitScout ProfitScout 2 minutos hace
$TKMO News: Tekumo Welcomes New Vice President of Strategic Partnerships

New York, Jan. 23, 2025 (GLOBE NEWSWIRE) -- -- Tekumo Inc. (TKMO or the "Company") announces the addition of industry leader, Randy Parks.

We are delighted to announce the appointment of Randy Park
TKMO
Konaploinks Konaploinks 2 minutos hace
Not sure Doc. Ask Siri. Lmao. All kidding aside. S K is a stop over to China Just a hop skip and a jump from here. Ya also gotta wonder if he’s stopping at Larry’s , Zuk’s , Sam’s and Jeff’s while he’s in the neighborhood?
IONQ
bucks2pennies bucks2pennies 2 minutos hace
GTCH has put so much time in creating patents and acquiring cash to do it that they never had time to contemplate how they were going MANAGE generating revenues from their patent effort. SHs now have to endure another extensive period of time for them to gain that management skill to do that as we
GTCH
Invest-in-America Invest-in-America 3 minutos hace
DGNX; Halted. (And my stupid POSTS, too.)
DGNX
linkvest linkvest 3 minutos hace
6s are up and waiting for a new home.... SLAP this Beast's ASK and make it hurt... Lets get out of the TRIPs this week.
ASII
Stevenvegas Stevenvegas 3 minutos hace
I blocked him
RNAZ
wadegarret wadegarret 3 minutos hace
Updated

COHR 1000 shares

GERN 50000 shares

Cash neg $10246
COHR GERN
shifty50 shifty50 4 minutos hace
Time to start buying again
UMAV
joe botts joe botts 4 minutos hace
Meaningless....means nothing.
prototype_101 prototype_101 4 minutos hace
LWLG won the Optical Integration award at ECOC for what? the OFC 200gb Modulator with World record performance metrics? Yes, but also more likely for the overall work LWLG has been doing to successfully Integrate their Polymers onto Silicon Photonics

We never got the PECC presentation
ASM LWLG
ORCA ORCA 4 minutos hace
MEDH.0016.FINALLY CURRENT.AND BROKERS ALLOW TRADING ON LINE:))
https://www.otcmarkets.com/stock/MEDH/disclosure
MEDH
dave79 dave79 4 minutos hace
Trading in TGLO for years has been held back by the Market Maker's for whatever reasons... TGLO should have been trading @ $'s based solely upon the fact Fred Jones has been our CEO since 2017 (verified via EVERY 10Q & 10k!), and the fact Delfin has held (at least, but we know more) then 71% of the
TGLO
cpeter7 cpeter7 4 minutos hace
I like Versus AI. Definitely running on a lot hype and not a lot of revenue. But they have Karl Friston the top neuroscientist in the world. His presenting those Atari results at Davos. I actually think Veritone and Verses AI should work together. Verses AI I think has superior models to LLMs. While
VERI
Controlledoilandgas Controlledoilandgas 4 minutos hace
Ahead of the release of our financial statements and disclosures which we anticipate will be tomorrow by end of day - the company has announced the official execution of the LOI between American Industries and Button Energy, ahead of official press distribution slated for early next week.  The Execu
AZRH
SlamDunk89 SlamDunk89 4 minutos hace
The old gap and trap…
UMAV
joe botts joe botts 4 minutos hace
Wow! Still REVOKED

Su Consulta Reciente

EU
CYAD
Celyad Oncology
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados